Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net income	$ 202.7	$ 327.7
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation	162.0	180.4
Deferred debt issuance cost amortization	1.6	2.2
Amortization of intangibles	32.2	30.4
Stock compensation	10.6	(11.0)
Equity in net earnings of affiliates, net of cash received	(28.0)	(28.6)
Deferred income tax provision	(11.3)	1.7
Other	(0.2)	2.3
Changes in operating assets and liabilities, net of effects from purchase of businesses:
Accounts and notes receivable, net	(76.0)	(151.4)
Inventories, net	(140.2)	(422.7)
Other current and noncurrent assets	(79.5)	(0.8)
Accounts payable	58.3	(74.7)
Accrued expenses	(35.0)	(96.9)
Other current and noncurrent liabilities	(25.0)	26.1
Total adjustments	(130.5)	(543.0)
Net cash provided by (used in) operating activities	72.2	(215.3)
Cash flows from investing activities:
Purchases of property, plant and equipment	(147.1)	(229.3)
Proceeds from sale of property, plant and equipment	1.2	2.2
Purchase of businesses, net of cash acquired	(25.4)	(130.4)
Investment in unconsolidated affiliates	(5.2)	0.0
Restricted cash	(0.4)	0.0
Net cash used in investing activities	(176.9)	(357.5)
Cash flows from financing activities:
Proceeds from debt obligations, net	462.3	450.6
Purchases and retirement of common stock	(187.5)	(340.9)
Payment of dividends to stockholders	(31.7)	(30.9)
Payment of minimum tax withholdings on stock compensation	(6.2)	(11.9)
Payment of debt issuance costs	(0.7)	(1.3)
Repurchase or conversion of convertible senior subordinated notes	0.0	(201.2)
Purchase of or distribution to noncontrolling interests	0.0	(6.1)
Net cash provided by (used in) financing activities	236.2	(141.7)
Effects of exchange rate changes on cash and cash equivalents	(69.8)	(11.8)
Increase (decrease) in cash and cash equivalents	61.7	(726.3)
Cash and cash equivalents, beginning of period	363.7	1,047.2
Cash and cash equivalents, end of period	$ 425.4	$ 320.9